Stock Quotes in this Article: ARQL, MSTX, ONTX, XXII

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

 

>>5 Blue-Chip Stocks to Trade for Gains

 

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

 

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

 

>>5 Stocks With Big Insider Buying

 

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

 

ArQule

 

ArQule (ARQL), a clinical-stage biotechnology company, researches and develops cancer therapeutics. This stock closed up 3.4% to $1.49 in Thursday's trading session.

 

Thursday's Range: $1.44-$1.54

52-Week Range: $1.29-$2.94

Thursday's Volume: 908,000

Three-Month Average Volume: 567,811

 

From a technical perspective, ARQL jumped higher here right above some near-term support at $1.40 with above-average volume. This move briefly pushed shares of ARQL back above its 50-day moving average of $1.53, before the stock closed just below that level at $1.49. This move is starting to push shares of ARQL within range of triggering a near-term breakout trade. That trade will hit if ARQL manages to take out some near-term overhead resistance levels at $1.54 to $1.60 with high volume.

 

Traders should now look for long-biased trades in ARQL as long as it's trending above some near-term support levels at $1.40 or at $1.35 and then once it sustains a move or close above those breakout levels with volume that hits near or above 567,811 shares. If that breakout hits soon, then ARQL will set up to re-test or possibly take out its next major overhead resistance levels at $1.66 to $1.78, or even $1.90 to $2.

 

Onconova Therapeutics

 

Onconova Therapeutics (ONTX), a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer. This stock closed up 2.5% to $5.15 in Thursday's trading session.

 

Thursday's Range: $4.97-$5.19

52-Week Range: $4.10-$31.13

Thursday's Volume: 132,000

Three-Month Average Volume: 216,102

 

From a technical perspective, ONTX trended modestly higher here with lighter-than-average volume. This stock has been uptrending over the last few weeks, with shares moving higher from its low of $4.10 to its recent high of $5.52. During that uptrend, shares of ONTX have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ONTX within range of triggering a near-term breakout trade. That trade will hit if ONTX manages to take out Thursday's intraday high of $5.19 to some more key overhead resistance at $5.52 with high volume.

 

Traders should now look for long-biased trades in ONTX as long as it's trending above some near-term support levels at $4.80 or at $4.50 and then once it sustains a move or close above those breakout levels with volume that hits near or above 216,102 shares. If that breakout gets underway soon, then ONTX will set up to re-test or possibly take out its next major overhead resistance levels at $5.83 to $6.27. Any high-volume move above those levels will then give ONTX a chance to tag $7.

 

Mast Therapeutics

 

Mast Therapeutics (MSTX), a biopharmaceutical company, focuses on developing therapies for serious or life-threatening diseases. This stock closed up 2.1% 65 cents per share in Thursday's trading session.

 

Thursday's Range: $0.63-$0.67

52-Week Range: $0.40-$1.10

Thursday's Volume: 1.11 million

Three-Month Average Volume: 1.88 million

 

From a technical perspective, MSTX spiked modestly higher here right above its 50-day moving average of 61 cents per share with decent upside volume. This stock has been trending sideways and consolidating for the last month, with shares moving between 60 cents on the downside and 72 cents on the upside. Shares of MSTX are now starting to push higher and into range of triggering a big breakout trade above the upper-end of its recent sideways trading chart pattern. That trade will hit if MSTX manages to clear some near-term overhead resistance levels at 68 to 72 cents per share with high volume.

 

Traders should now look for long-biased trades in MSTX as long as it's trending above some key near-term support at 60 cents per share and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.88 million shares. If that breakout materializes soon, then MSTX will set up to re-test or possibly take out its next major overhead resistance levels at 80 to 85 cents per share, or even 93 cents per share.

 

22nd Century Group

 

22nd Century Group (XXII), a plant biotechnology company, focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. This stock closed up 2.7% to $3.75 a share in Thursday's trading session.

 

Thursday's Range: $3.60-$3.75

52-Week Range: $0.67-$6.36

Thursday's Volume: 671,000

Three-Month Average Volume: 686,284

 

From a technical perspective, XXII spiked notably higher here right above some near-term support at $3.36 with decent upside volume. This stock has been uptrending strong for the last month, with shares moving higher from its low of $2.26 to its recent high of $3.87. During that uptrend, shares of XXII have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of XXII within range of triggering a big breakout trade. That trade will hit if XXII manages to take out some key overhead resistance levels at $3.87 to $4 with high volume.

 

Traders should now look for long-biased trades in XXII as long as it's trending above some near-term support at $3.36 and then once it sustains a move or close above those breakout levels with volume that hits near or above 686,284 shares. If that breakout gets set off soon, then XXII will set up to re-test or possibly take out its next major overhead resistance levels at $5 to $6, or even its 52-week high of $6.36.

 

To see more stocks that are making notable moves higher, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

 

-- Written by Roberto Pedone in Delafield, Wis.

 

RELATED LINKS:

 

 

 

 

Follow Stockpickr on Twitter and become a fan on Facebook.

 

At the time of publication, author had no positions in stocks mentioned.

 

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com.

 

You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.